Search

30 results

The week: Finally, some money for the cities

The week: Finally, some money for the cities

Money for the regions, Mud for political enemies, Solar for our neighbors


A customs boss, a police chief and a "very expensive" watch: the first strike of the new anti-corruption agency

A customs boss, a police chief and a "very expensive" watch: the first strike of the new anti-corruption agency

Two strange stories from last week converge into one


The biggest pharmaceutical companies: a duo joins the billion-dollar club

The biggest pharmaceutical companies: a duo joins the billion-dollar club

Two drug distributors - Sopharma Trading and Phoenix Pharma - crossed the BGN 1 billion mark for the first time in 2022



A smuggler for a day: how migrants pass through Bulgaria

A smuggler for a day: how migrants pass through Bulgaria

The story of a driver who transported refugees via the black market in Telegram


The week: A very sudden twist

The week: A very sudden twist

Slapping Russia in the face, Borissov is not corrupt, Open-air teaching gets a boost


Sopharma to acquire Serbia’s Pharmanova

Sopharma to acquire Serbia’s Pharmanova

The deal will be carried out in stages within the next two years



Build the damn roads. Build the damn railways. Do something, for Christ’s sake

Build the damn roads. Build the damn railways. Do something, for Christ’s sake

Build the roads, search for gas in the sea, a Ukrainian hit-list and Lukoil is in for some trouble






Biggest pharma companies’ revenue grows 10% in 2021

Biggest pharma companies’ revenue grows 10% in 2021

Leaders Sopharma Trading and Phoenix approach a turnover of billion levs each






The dangerous attack of antibiotics in Bulgaria

The dangerous attack of antibiotics in Bulgaria

Sales of antimicrobial products reached a new high of 184 million BGN last year with 12 million packs sold in pharmacies alone


How superstition proved stronger than vaccines in Bulgaria

How superstition proved stronger than vaccines in Bulgaria

Kapital Insights and Friedrich Naumann Foundation present the second installment of "The Chronicles of the Infodemic"